LIC sells 2.13% stake in Dr Reddy’s Laboratories

14 May 2013 Evaluate

Life Insurance Corporation of India (LIC), the country’s largest insurer has sold 3,620,088 shares constituting 2.13% stake in pharma major Dr Reddy’s Laboratories in an open market transaction between January 10 and May 10. Pursuant to this, LIC’s stake has been reduced to 4.1% in the company. The promoters had 25.56% stake while the foreign institutional investors and domestic institutional investors hold 29.66% and 11.03% respectively while others hold 33.75%.

Dr. Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1279.65 6.70 (0.53%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×